This article is the first of a series of articles detailing the development of near-infrared (NIR) methods for solid-dosage form analysis. Experiments were conducted at the Duquesne University Center for Pharmaceutical Technology to qualify the capabilities of instrumentation and sample handling systems, evaluate the potential effect of one source of a process signature on calibration development, and compare the utility of reflection and transmission data collection methods. A database of 572 production-scale sample spectra was used to evaluate the interbatch spectral variability of samples produced under routine manufacturing conditions. A second database of 540 spectra from samples produced under various compression conditions was analyzed to determine the feasibility of pooling spectral data acquired from samples produced at diverse scales. Instrument qualification tests were performed, and appropriate limits for instrument performance were established. To evaluate the repeatability of the sample positioning system, multiple measurements of a single tablet were collected. With the application of appropriate spectral preprocessing techniques, sample repositioning error was found to be insignificant with respect to NIR analyses of product quality attributes. Sample shielding was demonstrated to be unnecessary for transmission analyses. A process signature was identified in the reflection data. Additional tests demonstrated that the process signature was largely orthogonal to spectral variation because of hardness. Principal component analysis of the compression sample set data demonstrated the potential for quantitative model development. For the data sets studied, reflection analysis was demonstrated to be more robust than transmission analysis.
The methods most commonly employed to determine active ingredient content in solid drug formulations involve dissolution of the sample. While these methods are capable of accurate and precise performance, the sample preparation required limits their use in quality-control applications to an occasional sample. There is a need for nondestructive methods capable of rapidly determining the active ingredient content in drug formulations. Spectroscopic methods of analysis have the potential for making the determinations with little or no sample preparation; hence these methods might be applied as at-line product quality monitors. We have investigated the use of diffuse reflectance infrared and Raman spectroscopies for the determination of bucindolol content in solid drug formulations. In experiments on formulations containing 0 to 100 mg of the active ingredient, the standard error of prediction with the use of either spectroscopic method was about 2.0 mg. The Raman spectroscopic method involved virtually no sample preparation, and the spectroscopic data can be collected rapidly; hence Raman spectroscopy shows very good potential as an at-line quality control monitor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.